TriSalus Life Sciences Warrant
TLSIW
25 hedge funds and large institutions have $5.77M invested in TriSalus Life Sciences Warrant in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.
6% less capital invested
Capital invested by funds: $6.13M → $5.77M (-$365K)
7% less funds holding
Funds holding: 27 → 25 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$533K |
| 2 |
DM
Deerfield Management
New York
|
+$309K |
| 3 |
MS
Maven Securities
St Helier,
Jersey
|
+$15.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.57K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Citadel Advisors
Miami,
Florida
| – | -$184K | -185,587 | Closed |
|
|
PMAM
27
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| – | -$76K | -74,999 | Closed |
|
|
FTCM
28
Fir Tree Capital Management
New York
| – | -$41K | -41,665 | Closed |
|
|
CAC
29
Cowen and Company
New York
| – | -$28K | -27,500 | Closed |
|
|
PI
30
PEAK6 Investments
Chicago,
Illinois
| – | -$245K | -25,308 | Closed |
|
TLSIW Hedge Fund Activity: Q3 2021 in Review
25 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2021, worth a combined $5.77M — down 6% from $6.13M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TLSIW and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was Magnetar Financial, opening a new position worth an estimated $533K. The largest seller was PEAK6 Investments, exiting entirely with an estimated $245K sold.
- 25 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2021, down from 27 in Q2 2021.
- Funds reported $5.77M of TriSalus Life Sciences Warrant stock for Q3 2021, down 6% quarter-over-quarter.
- 3 funds opened new TriSalus Life Sciences Warrant positions in Q3 2021 and 5 closed out, a net change of -2 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q3 2021 was Magnetar Financial, an estimated $533K added.
- The largest TriSalus Life Sciences Warrant seller in Q3 2021 was PEAK6 Investments, an estimated $245K sold.
Based on aggregated 13F filings for Q3 2021.